Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Societal CDMO, Inc. has entered into a three-year manufacturing and supply agreement with InfectoPharm for Ritalin LA® capsules (methylphenidate hydrochloride extended-release capsules) in Europe.
read more
Societal CDMO, Inc. has been selected by AmyriAD Pharma to provide CDMO services to support the ongoing clinical development of AD101. The compound, a novel T-type calcium channel modulator, is currently in clinical development for the treatment of ...
read more
Societal CDMO, Inc. announced a key new customer project utilizing its automated fill/finish line and lyophilization unit at the company’s San Diego facility.
read more
Thursday, September 24, 2020
Sobrera and Recipharm have entered into an agreement for the formulation development and manufacturing of SO-001, a new oral treatment for Alcohol Use Disorder.
read more
Skyland Analytics announced the appointment of James C. Mullen to Skyland's Advisory Board.
read more
Tuesday, January 06, 2015
SK Capital Partners, a private investment firm with a disciplined focus on the specialty materials, chemicals and healthcare sectors, announced today that is has completed a controlling strategic growth investment in Halo Pharmaceutical, a premiere ...
read more
Wednesday, November 22, 2017
SK Capital completed its previously announced acquisition of Perrigo Company API business.
read more
Sirnaomics and PNI jointly announced a partnership on the development and manufacture of Sirnaomics polypeptide nanoparticle-based RNAi therapeutic product.
read more
Tuesday, October 03, 2017
SIRION Biotech GmbH and Vibalogics GmbH, have signed a strategic partnership agreement designed to meet demand from gene therapy companies for a start-to-finish AAV service.
read more
Sinocompound Catalysts has announced the construction of a new production plant in Tongling, Anhui Province, China.
read more
Silo Pharma, Inc. has entered into an agreement with Frontage Laboratories, a CRO (contract research organization), providing integrated, science-driven, product development services throughout the drug discovery and development process that enable ...
read more
Tuesday, January 23, 2018
Under the expanded agreement, ABL will provide development, manufacturing & QC release testing services for SillaJen's pipeline product, JX-970.
read more
Shire has filed its first submission to the United States Food and Drug Administration for the company’s new plasma manufacturing facility in Covington, Georgia.
read more
Tuesday, January 25, 2022
Sharp has completed the construction of new purpose-built production suites to facilitate the packaging, storage and distribution of gene therapies, at its facility in Heerenveen, The Netherlands.
read more
Sharp acquired the new Bethlehem facility for $14m in 2017 and has invested a further $9 million on refitting the facility and relocating services from its Phoenixville site.
read more